{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:04:39Z","timestamp":1790910279791,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["22K16308"],"award-info":[{"award-number":["22K16308"]}]},{"name":"JSPS KAKENHI","award":["20K08718"],"award-info":[{"award-number":["20K08718"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-69496-z","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T09:01:46Z","timestamp":1723626106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["C-Mannosyl tryptophan is a novel biomarker for thrombocytosis of myeloproliferative neoplasms"],"prefix":"10.1038","volume":"14","author":[{"given":"Shotaro","family":"Tabata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Inai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kosako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Shide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shino","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taka-aki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sonoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"69496_CR1","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.3390\/molecules26175258","volume":"26","author":"S Minakata","year":"2021","unstructured":"Minakata, S. et al. Protein C-Mannosylation and C-Mannosyl tryptophan in chemical biology and medicine. Molecules 26, 5258. https:\/\/doi.org\/10.3390\/molecules26175258 (2021).","journal-title":"Molecules"},{"key":"69496_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.18388\/abp.2000_3996","volume":"47","author":"A Furmanek","year":"2000","unstructured":"Furmanek, A. & Hofsteenge, J. Protein C-mannosylation: Facts and questions. Acta Biochim. Pol. 47, 781\u2013789 (2000).","journal-title":"Acta Biochim. Pol."},{"key":"69496_CR3","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1073\/pnas.1613165114","volume":"114","author":"A Shcherbakova","year":"2017","unstructured":"Shcherbakova, A. et al. Distinct C-mannosylation of netrin receptor thrombospondin type 1 repeats by mammalian DPY19L1 and DPY19L3. Proc. Natl Acad. Sci. USA 114, 2574\u20132579. https:\/\/doi.org\/10.1073\/pnas.1613165114 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"69496_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.molcel.2013.03.003","volume":"50","author":"FF Buettner","year":"2013","unstructured":"Buettner, F. F. et al. C. elegans DPY-19 is a C-mannosyltransferase glycosylating thrombospondin repeats. Mol. Cell 50, 295\u2013302. https:\/\/doi.org\/10.1016\/j.molcel.2013.03.003 (2013).","journal-title":"Mol. Cell"},{"key":"69496_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1091\/mbc.E15-06-0373","volume":"27","author":"Y Niwa","year":"2016","unstructured":"Niwa, Y. et al. Identification of DPY19L3 as the C-mannosyltransferase of R-spondin1 in human cells. Mol. Biol. Cell 27, 744\u2013756. https:\/\/doi.org\/10.1091\/mbc.E15-06-0373 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"69496_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10719-020-09938-8","volume":"37","author":"S Minakata","year":"2020","unstructured":"Minakata, S. et al. Monomeric C-mannosyl tryptophan is a degradation product of autophagy in cultured cells. Glycoconj. J. 37, 635\u2013645. https:\/\/doi.org\/10.1007\/s10719-020-09938-8 (2020).","journal-title":"Glycoconj. J."},{"key":"69496_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10719-017-9807-2","volume":"35","author":"TJ Hossain","year":"2018","unstructured":"Hossain, T. J. et al. Enrichment and characterization of a bacterial mixture capable of utilizing C-mannosyl tryptophan as a carbon source. Glycoconj. J. 35, 165\u2013176. https:\/\/doi.org\/10.1007\/s10719-017-9807-2 (2018).","journal-title":"Glycoconj. J."},{"key":"69496_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/oxfordjournals.jbchem.a124343","volume":"115","author":"K Horiuchi","year":"1994","unstructured":"Horiuchi, K. et al. A hydrophilic tetrahydro-beta-carboline in human urine. J. Biochem. 115, 362\u2013366. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a124343 (1994).","journal-title":"J. Biochem."},{"key":"69496_CR9","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1038\/s41598-019-41278-y","volume":"9","author":"S Sakurai","year":"2019","unstructured":"Sakurai, S. et al. A novel assay for detection and quantification of C-mannosyl tryptophan in normal or diabetic mice. Sci. Rep. 9, 4675. https:\/\/doi.org\/10.1038\/s41598-019-41278-y (2019).","journal-title":"Sci. Rep."},{"key":"69496_CR10","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1038\/s41598-021-81479-y","volume":"11","author":"S Morita","year":"2021","unstructured":"Morita, S. et al. Quantification of serum C-mannosyl tryptophan by novel assay to evaluate renal function and vascular complications in patients with type 2 diabetes. Sci. Rep. 11, 1946. https:\/\/doi.org\/10.1038\/s41598-021-81479-y (2021).","journal-title":"Sci. Rep."},{"key":"69496_CR11","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Guideline on bioanalytical method validation. Eur. Med. Agency. 1\u201323 (2011)."},{"key":"69496_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3892\/ol.2019.11161","volume":"19","author":"N Iwahashi","year":"2020","unstructured":"Iwahashi, N. et al. C-mannosyl tryptophan increases in the plasma of patients with ovarian cancer. Oncol. Lett. 19, 908\u2013916. https:\/\/doi.org\/10.3892\/ol.2019.11161 (2020).","journal-title":"Oncol. Lett."},{"key":"69496_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0002-9343(00)00693-8","volume":"110","author":"R Takahira","year":"2001","unstructured":"Takahira, R. et al. Tryptophan glycoconjugate as a novel marker of renal function. Am. J. Med. 110, 192\u2013197. https:\/\/doi.org\/10.1016\/S0002-9343(00)00693-8 (2001).","journal-title":"Am. J. Med."},{"key":"69496_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/j.1523-1755.2004.00521.x","volume":"65","author":"K Yonemura","year":"2004","unstructured":"Yonemura, K. et al. The diagnostic value of serum concentrations of 2-(alpha-mannopyranosyl)-L-tryptophan for normal renal function. Kidney Int. 65, 1395\u20131399. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00521.x (2004).","journal-title":"Kidney Int."},{"key":"69496_CR15","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/ki.2013.497","volume":"85","author":"MA Niewczas","year":"2014","unstructured":"Niewczas, M. A. et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: Metabolomic study. Kidney Int. 85, 1214\u20131224. https:\/\/doi.org\/10.1038\/ki.2013.497 (2014).","journal-title":"Kidney Int."},{"key":"69496_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1681\/ASN.2014111099","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P. et al. A metabolome-wide association study of kidney function and disease in the general population. J. Am. Soc. Nephrol. 27, 1175\u20131188. https:\/\/doi.org\/10.1681\/ASN.2014111099 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"69496_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1210\/jc.2015-3345","volume":"101","author":"A Solini","year":"2016","unstructured":"Solini, A. et al. Prediction of declining renal function and albuminuria in patients with type 2 diabetes by metabolomics. J. Clin. Endocrinol. Metab. 101, 696\u2013704. https:\/\/doi.org\/10.1210\/jc.2015-3345 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"69496_CR18","doi-asserted-by":"publisher","first-page":"17400","DOI":"10.1038\/s41598-017-17107-5","volume":"7","author":"P Sekula","year":"2017","unstructured":"Sekula, P. et al. From discovery to translation: Characterization of C-mannosyltryptophan and pseudouridine as markers of kidney function. Sci. Rep. 7, 17400. https:\/\/doi.org\/10.1038\/s41598-017-17107-5 (2017).","journal-title":"Sci. Rep."},{"key":"69496_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2337\/dc16-0173","volume":"40","author":"MA Niewczas","year":"2017","unstructured":"Niewczas, M. A. et al. Circulating modified metabolites and a risk of ESRD in patients with type 1 diabetes and chronic kidney disease. Diabetes Care. 40, 383\u2013390. https:\/\/doi.org\/10.2337\/dc16-0173 (2017).","journal-title":"Diabetes Care."},{"key":"69496_CR20","doi-asserted-by":"publisher","first-page":"1058007","DOI":"10.3389\/fendo.2023.1058007","volume":"14","author":"S Morita","year":"2023","unstructured":"Morita, S. et al. Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: A twelve-month follow-up study. Front. Endocrinol. 14, 1058007. https:\/\/doi.org\/10.3389\/fendo.2023.1058007 (2023).","journal-title":"Front. Endocrinol."},{"key":"69496_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/0004563215608875","volume":"53","author":"K Ichihara","year":"2016","unstructured":"Ichihara, K. et al. Collaborative derivation of reference intervals for major clinical laboratory tests in Japan. Ann. Clin. Biochem. 53, 347\u2013356. https:\/\/doi.org\/10.1177\/0004563215608875 (2016).","journal-title":"Ann. Clin. Biochem."},{"key":"69496_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1182\/blood-2016-10-695957","volume":"129","author":"E Rumi","year":"2017","unstructured":"Rumi, E. & Cazzola, M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood 129, 680\u2013692. https:\/\/doi.org\/10.1182\/blood-2016-10-695957 (2017).","journal-title":"Blood"},{"key":"69496_CR23","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/ajh.26008","volume":"95","author":"A Tefferi","year":"2020","unstructured":"Tefferi, A. & Barbui, T. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am. J. Hematol. 95, 1599\u20131613. https:\/\/doi.org\/10.1002\/ajh.26008 (2020).","journal-title":"Am. J. Hematol."},{"key":"69496_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1055\/s-2006-939430","volume":"32","author":"P Johansson","year":"2006","unstructured":"Johansson, P. Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia. Semin. Thromb. Hemost. 32, 171\u2013173. https:\/\/doi.org\/10.1055\/s-2006-939430 (2006).","journal-title":"Semin. Thromb. Hemost."},{"key":"69496_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ajh.21129","volume":"83","author":"X Ma","year":"2008","unstructured":"Ma, X. et al. Prevalence of polycythemia vera and essential thrombocythemia. Am. J. Hematol. 83, 359\u2013362. https:\/\/doi.org\/10.1002\/ajh.21129 (2008).","journal-title":"Am. J. Hematol."},{"key":"69496_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.leu.2404914","volume":"22","author":"G Barosi","year":"2008","unstructured":"Barosi, G. et al. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A consensus statement from the International Working Group for Myelofibrosis Research and Treatment. Leukemia 22, 437\u2013438. https:\/\/doi.org\/10.1038\/sj.leu.2404914 (2008).","journal-title":"Leukemia"},{"key":"69496_CR27","unstructured":"Swerdlow, S. H. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. rev. 4th edn (International Agency for Research on Cancer, 2017)."},{"key":"69496_CR28","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele, J. et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90, 1128\u20131132 (2005).","journal-title":"Haematologica"},{"key":"69496_CR29","doi-asserted-by":"publisher","first-page":"101735","DOI":"10.18632\/oncotarget.21594","volume":"8","author":"E Rumi","year":"2017","unstructured":"Rumi, E. et al. Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria. Oncotarget 8, 101735\u2013101744. https:\/\/doi.org\/10.18632\/oncotarget.21594 (2017).","journal-title":"Oncotarget"},{"key":"69496_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.leukres.2017.06.001","volume":"59","author":"L Masarova","year":"2017","unstructured":"Masarova, L. et al. Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis. Leuk. Res. 59, 110\u2013116. https:\/\/doi.org\/10.1016\/j.leukres.2017.06.001 (2017).","journal-title":"Leuk. Res."},{"key":"69496_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00277-023-05528-4","volume":"103","author":"K Shide","year":"2024","unstructured":"Shide, K. et al. Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis. Ann. Hematol. 103, 97\u2013103. https:\/\/doi.org\/10.1007\/s00277-023-05528-4 (2024).","journal-title":"Ann. Hematol."},{"key":"69496_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bbrc.2015.10.116","volume":"468","author":"Y Sasazawa","year":"2015","unstructured":"Sasazawa, Y. et al. C-Mannosylation of thrombopoietin receptor (c-Mpl) regulates thrombopoietin-dependent JAK-STAT signaling. Biochem. Biophys. Res. Commun. 468, 262\u2013268. https:\/\/doi.org\/10.1016\/j.bbrc.2015.10.116 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"69496_CR33","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","volume":"124","author":"A Tefferi","year":"2014","unstructured":"Tefferi, A. et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood 124, 2507\u20132513. https:\/\/doi.org\/10.1182\/blood-2014-05-579136 (2014).","journal-title":"Blood"},{"key":"69496_CR34","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3324\/haematol.13346","volume":"93","author":"F Passamonti","year":"2008","unstructured":"Passamonti, F. et al. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: A study of 605 patients. Haematologica 93, 1645\u20131651. https:\/\/doi.org\/10.3324\/haematol.13346 (2008).","journal-title":"Haematologica"},{"key":"69496_CR35","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.3324\/haematol.2013.101733","volume":"99","author":"JC Hern\u00e1ndez-Boluda","year":"2014","unstructured":"Hern\u00e1ndez-Boluda, J. C. et al. The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis. Haematologica 99, e55\u2013e57. https:\/\/doi.org\/10.3324\/haematol.2013.101733 (2014).","journal-title":"Haematologica"},{"key":"69496_CR36","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ajh.24377","volume":"91","author":"G Rotunno","year":"2016","unstructured":"Rotunno, G. et al. Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group. Am. J. Hematol. 91, 681\u2013686. https:\/\/doi.org\/10.1002\/ajh.24377 (2016).","journal-title":"Am. J. Hematol."},{"key":"69496_CR37","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","volume":"29","author":"T Barbui","year":"2011","unstructured":"Barbui, T. et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: An international study. J. Clin. Oncol. 29, 3179\u20133184. https:\/\/doi.org\/10.1200\/JCO.2010.34.5298 (2011).","journal-title":"J. Clin. Oncol."},{"key":"69496_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102378","volume":"67","author":"D Xiang","year":"2024","unstructured":"Xiang, D. et al. Development and validation of a model for the early prediction of progression from essential thrombocythemia to post-essential thrombocythemia myelofibrosis: A multicentre retrospective study. EClinicalMedicine 67, 102378. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102378 (2024).","journal-title":"EClinicalMedicine"},{"key":"69496_CR39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2141.2005.05674.x","volume":"130","author":"KE Panteli","year":"2005","unstructured":"Panteli, K. E. et al. Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases. Br. J. Haematol. 130, 709\u2013715. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05674.x (2005).","journal-title":"Br. J. Haematol."},{"key":"69496_CR40","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","volume":"29","author":"A Tefferi","year":"2011","unstructured":"Tefferi, A. et al. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: A comprehensive cytokine profiling study. J. Clin. Oncol. 29, 1356\u20131363. https:\/\/doi.org\/10.1200\/JCO.2010.32.9490 (2011).","journal-title":"J. Clin. Oncol."},{"key":"69496_CR41","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.exphem.2014.01.006","volume":"42","author":"E Pourcelot","year":"2014","unstructured":"Pourcelot, E. et al. Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications. Exp. Hematol. 42, 360\u2013368. https:\/\/doi.org\/10.1016\/j.exphem.2014.01.006 (2014).","journal-title":"Exp. Hematol."},{"key":"69496_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000371","volume":"4","author":"NF \u00d8bro","year":"2020","unstructured":"\u00d8bro, N. F. et al. Longitudinal cytokine profiling identifies GRO-alpha and EGF as potential biomarkers of disease progression in essential thrombocythemia. Hemasphere 4, e371. https:\/\/doi.org\/10.1097\/HS9.0000000000000371 (2020).","journal-title":"Hemasphere"},{"key":"69496_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.leu.2405043","volume":"22","author":"K Shide","year":"2008","unstructured":"Shide, K. et al. Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F. Leukemia 22, 87\u201395. https:\/\/doi.org\/10.1038\/sj.leu.2405043 (2008).","journal-title":"Leukemia"},{"key":"69496_CR44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41375-020-0880-3","volume":"35","author":"Y Ozono","year":"2021","unstructured":"Ozono, Y. et al. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice. Leukemia 35, 454\u2013467. https:\/\/doi.org\/10.1038\/s41375-020-0880-3 (2021).","journal-title":"Leukemia"},{"key":"69496_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10719-021-10030-y","volume":"39","author":"K Nishitsuji","year":"2022","unstructured":"Nishitsuji, K. et al. Thrombospondin type 1 repeat-derived C-mannosylated peptide attenuates synaptogenesis of cortical neurons induced by primary astrocytes via TGF-\u03b2. Glycoconj. J. 39, 701\u2013710. https:\/\/doi.org\/10.1007\/s10719-021-10030-y (2022).","journal-title":"Glycoconj. J."},{"key":"69496_CR46","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1074\/jbc.272.2.1323","volume":"272","author":"DJ Dorahy","year":"1997","unstructured":"Dorahy, D. J. et al. Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor. J. Biol. Chem. 272, 1323\u20131330. https:\/\/doi.org\/10.1074\/jbc.272.2.1323 (1997).","journal-title":"J. Biol. Chem."},{"key":"69496_CR47","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1074\/jbc.M010091200","volume":"276","author":"A Bonnefoy","year":"2001","unstructured":"Bonnefoy, A. et al. A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor. J. Biol. Chem. 276, 5605\u20135612. https:\/\/doi.org\/10.1074\/jbc.M010091200 (2001).","journal-title":"J. Biol. Chem."},{"key":"69496_CR48","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1182\/blood-2004-12-4856","volume":"107","author":"A Bonnefoy","year":"2006","unstructured":"Bonnefoy, A. et al. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood 107, 955\u2013964. https:\/\/doi.org\/10.1182\/blood-2004-12-4856 (2006).","journal-title":"Blood"},{"key":"69496_CR49","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006627","volume":"2","author":"PR Lawler","year":"2012","unstructured":"Lawler, P. R. & Lawler, J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb. Perspect. Med. 2, a006627. https:\/\/doi.org\/10.1101\/cshperspect.a006627 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"69496_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4267\/2042\/70774","volume":"24","author":"JS Isenberg","year":"2020","unstructured":"Isenberg, J. S. & Roberts, D. D. THBS1 (thrombospondin-1). Atlas Genet. Cytogenet. Oncol. Haematol. 24, 291\u2013299. https:\/\/doi.org\/10.4267\/2042\/70774 (2020).","journal-title":"Atlas Genet. Cytogenet. Oncol. Haematol."},{"key":"69496_CR51","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1074\/jbc.M008073200","volume":"276","author":"J Hofsteenge","year":"2001","unstructured":"Hofsteenge, J. et al. C-mannosylation and O-fucosylation of the thrombospondin type 1 module. J. Biol. Chem. 276, 6485\u20136498. https:\/\/doi.org\/10.1074\/jbc.M008073200 (2001).","journal-title":"J. Biol. Chem."},{"key":"69496_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00277-010-1024-z","volume":"90","author":"M Muth","year":"2011","unstructured":"Muth, M. et al. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia. Ann. Hematol. 90, 33\u201340. https:\/\/doi.org\/10.1007\/s00277-010-1024-z (2011).","journal-title":"Ann. Hematol."},{"key":"69496_CR53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/bs.mcb.2017.08.021","volume":"143","author":"JM Sipes","year":"2018","unstructured":"Sipes, J. M. et al. Thrombospondins: Purification of human platelet thrombospondin-1. Methods Cell Biol. 143, 347\u2013369. https:\/\/doi.org\/10.1016\/bs.mcb.2017.08.021 (2018).","journal-title":"Methods Cell Biol."},{"key":"69496_CR54","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1182\/blood-2011-02-337337","volume":"118","author":"N Maugeri","year":"2011","unstructured":"Maugeri, N. et al. Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia. Blood 118, 3359\u20133366. https:\/\/doi.org\/10.1182\/blood-2011-02-337337 (2011).","journal-title":"Blood"},{"key":"69496_CR55","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s12185-018-2421-7","volume":"107","author":"K Misawa","year":"2018","unstructured":"Misawa, K. et al. Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms. Int. J. Hematol. 107, 673\u2013680. https:\/\/doi.org\/10.1007\/s12185-018-2421-7 (2018).","journal-title":"Int. J. Hematol."},{"key":"69496_CR56","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1111\/cas.13272","volume":"108","author":"R Tsunedomi","year":"2017","unstructured":"Tsunedomi, R. et al. Rapid and sensitive detection of UGT1A1 polymorphisms associated with irinotecan toxicity by a novel DNA microarray. Cancer Sci. 108, 1504\u20131509. https:\/\/doi.org\/10.1111\/cas.13272 (2017).","journal-title":"Cancer Sci."},{"key":"69496_CR57","doi-asserted-by":"publisher","first-page":"9754","DOI":"10.1021\/ja990926a","volume":"121","author":"S Manabe","year":"1999","unstructured":"Manabe, S. & Ito, Y. Total synthesis of novel subclass of glyco-amino acid structure motif: C2-\u03b1-l-C-Mannosylpyranosyl-L-tryptophan. J. Am. Chem. Soc. 121, 9754\u20139755. https:\/\/doi.org\/10.1021\/ja990926a (1999).","journal-title":"J. Am. Chem. Soc."},{"key":"69496_CR58","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 (2013).","journal-title":"Bone Marrow Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69496-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69496-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69496-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T09:02:15Z","timestamp":1723626135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69496-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["69496"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-69496-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18858"}}